Grounds Real Estate Development AG (DE:AMMN)
XETRA:AMMN
Germany Market
Holding DE:AMMN?
Track your performance easily

Grounds Real Estate Development AG (AMMN) Income Statement

0 Followers

Grounds Real Estate Development AG Income Statement

Last quarter (Q2 2022), Grounds Real Estate Development AG's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, Grounds Real Estate Development AG's net income was €―. See Grounds Real Estate Development AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-€ 30.00M€ 30.29M€ 13.09M€ 30.16M€ 18.95M
Cost of Revenue
-€ 20.91M€ 25.22M€ 10.66M€ 20.96M€ 15.05M
Gross Profit
-€ 9.08M€ 5.07M€ 2.42M€ 9.20M€ 3.89M
Operating Expense
-€ 3.81M€ 2.82M€ 1.70M€ 3.02M€ 2.17M
Operating Income
-€ 5.27M€ 2.25M€ 719.60K€ 6.18M€ 1.72M
Net Non Operating Interest Income Expense
-€ -2.12M€ -985.00K€ -1.98M€ -2.72M€ -377.76K
Other Income Expense
------
Pretax Income
-€ 7.05M€ 5.12M€ -17.73K€ 8.65M€ 1.36M
Tax Provision
-€ 1.97M€ 1.11M€ -71.97K€ 4.46M€ 158.45K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ 5.10M€ 3.60M€ 2.26K€ 3.52M€ 1.19M
Basic EPS
-€ 0.29€ 0.22€ <0.01--
Diluted EPS
-€ 0.29€ 0.22€ <0.01--
Basic Average Shares
-€ 17.81M€ 16.23M€ 15.11M--
Diluted Average Shares
-€ 17.81M€ 17.81M€ 15.11M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----€ 175.00K€ 28.00K
Total Expenses
-€ 24.72M€ 28.05M€ 12.37M€ 23.98M€ 17.23M
Net Income From Continuing And Discontinued Operation
-€ 5.10M€ 3.60M€ 2.26K€ 3.52M€ 1.19M
Normalized Income
-€ 5.10M€ 3.60M€ -609.74K€ -248.41K€ 1.16M
Interest Expense
-€ 2.27M€ 1.10M€ 2.06M€ 2.78M€ 866.92K
EBIT
-€ 9.32M€ 6.22M€ 2.04M€ 11.43M€ 2.22M
EBITDA
-€ 9.49M€ 6.28M€ 2.07M€ 11.46M€ 2.23M
Currency in EUR

Grounds Real Estate Development AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis